華夏銀行(600015.SH):發行不超200億元小型微型企業貸款專項金融債券獲監管部門批准
格隆匯6月5日丨華夏銀行(600015.SH)公佈,公司近日收到《中國銀保監會關於華夏銀行發行小微企業專項金融債券的批覆》(銀保監復〔2020〕326號)和《中國人民銀行准予行政許可決定書》(銀市場許准予字〔2020〕第101號),同意公司在全國銀行間債券市場公開發行不超過200億元人民幣金融債券,募集資金專項用於發放小型微型企業貸款。
公司將在每期債券發行結束後10個工作日內向中國人民銀行報告本期債券的發行情況,並在發行完畢後一個月內就有關發行情況向中國銀行保險監督管理委員會書面報告。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.